Table II.
Comparison of delivery characteristics and fetal outcomes between groups.
| ACS treatment group (n= 354) | Control group (n= 5900) | p value | |
|---|---|---|---|
| Gestational week at delivery | 38.6 ± 0.9 | 38.7 ± 1.0 | 0.290& |
| Male sex, n (%) | 176 (49.7%) | 2714 (46.0%) | 0.174* |
| Fetal weight, g | 3190 ± 340 | 3170 ± 324 | 0.589& |
| Labor induction, n (%) | 105 (29.6%) | 1657 (28.1%) | 0.522* |
| Vaginal delivery, n (%) | 268 (75.7%) | 4602 (78%) | 0.316* |
| 5 min Apgar <7, n (%) | 1 (0.28%) | 34 (0.58%) | 0.721* |
| Neonatal hyperbilirubinemia, n (%) | 20 (5.6%) | 564 (9.6%) | 0.014* |
| Length of stay in the neonatal unit, day | 2.00 ± 0.81 | 1.69 ± 1.18 | 0.418& |
Pearson chi-square tests.
Parametric comparisons were made using the t-test, and nonparametric comparisons were made using the Mann–Whitney U test. Values are expressed as mean ± standard deviation or n(%).